6.84
+0.12
+(1.71%)
At close: January 10 at 1:20:09 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-20,477.00
18,228.00
100,131.00
-84,746.00
-80,696.00
Investing Cash Flow
-45,243.00
-31,388.00
-209,791.00
7,493.00
-15,949.00
Financing Cash Flow
172,354.00
84,516.00
123,710.00
-2,613.00
207,883.00
End Cash Position
190,080.00
218,472.00
148,519.00
132,994.00
207,530.00
Capital Expenditure
-24,039.00
-30,957.00
-6,215.00
-5,657.00
-7,524.00
Issuance of Capital Stock
174,554.00
90,404.00
134,484.00
94.00
217,918.00
Repayment of Debt
-2,200.00
-3,849.00
-2,843.00
-2,707.00
-2,096.00
Free Cash Flow
-44,516.00
-12,729.00
93,916.00
-90,403.00
-88,220.00
12/31/2020 - 7/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
41O.F Outlook Therapeutics, Inc.
2.0600
+0.98%
6C1.SG CytomX Therapeutics Inc
0.8410
-9.52%
SG7.MU Sage Therapeutics Inc
5.73
0.00%
05Y.F Vivoryon Therapeutics N.V.
2.0200
+1.51%
BVNKF Bavarian Nordic A/S
26.25
0.00%
VVY.AS Vivoryon Therapeutics N.V.
1.9900
-1.49%
POLB.L Poolbeg Pharma PLC
5.15
-8.04%
PHARM.AS Pharming Group N.V.
0.9105
-2.10%
ACLX Arcellx, Inc.
69.08
-4.40%
INSM Insmed Incorporated
65.25
-0.72%